Stephen P Squinto Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Stephen P Squinto is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 131,652 shares of SWTX, which is worth approximately $5.1 Million. The most recent transaction as insider was on May 19, 2022, when has been sold 4,818 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

0% 3M change

0% 12M change

Total Value Held $5.1 Million

STEPHEN P SQUINTO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2022	BUY Grant, award, or other acquisition	-	4,818 Added 3.53%	131,652 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,106 Added 0.86%	126,834 Common Stock
Apr 28 2021	SELL Open market or private sale	$1,465,402 $76.2 p/Share	19,231 Reduced 13.27%	125,728 Common Stock
Apr 27 2021	SELL Open market or private sale	$15,085 $75.05 p/Share	201 Reduced 0.14%	144,959 Common Stock
Apr 15 2021	SELL Open market or private sale	$79,286 $75.01 p/Share	1,057 Reduced 0.72%	145,160 Common Stock
Apr 14 2021	SELL Open market or private sale	$38,366 $75.08 p/Share	511 Reduced 0.35%	146,217 Common Stock

Also insider at

CMMB

Chemomab Therapeutics Ltd. Healthcare

Director

CMPX

Compass Therapeutics, Inc. Healthcare

Director

SPS